Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17853693 | 1.00 | DHODH (0.50) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853561 | 1.00 | DHODH (0.50) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853546 | 1.00 | DHODH (0.50) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853486 | 1.00 | DHODH (0.50) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853564 | 1.00 | DHODH (0.50) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL19397640 | 0.96 | CYP19A1 (0.49) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL19275993 | 0.96 | CYP19A1 (0.49) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853607 | 0.95 | DHODH (0.46) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853555 | 0.94 | DHODH (0.46) | DHODHCYP19A1MEN1KMT2AALDH1A1 | |
| SCHEMBL17853490 | 0.94 | DHODH (0.45) | DHODHCYP19A1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2020-03-03 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | C1S, AOC2, L1CAM | DHODH 2746/4885CYP19A1 515/4885MEN1 682/4885 |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | L1CAM, C1S, F10 | DHODH 3884/4885CYP19A1 673/4885MEN1 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.